06.01.17
Envigo’s Research Models and Services (RMS) facility in Hyderabad, India has been granted full accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International Council.
This is the first accreditation of Envigo sites in 2017 and the sixth in total since the launch of the new company in 2015. All of Envigo’s U.S. sites are already AAALAC accredited.
The isolator breeding facility in Hyderabad was purpose-built in 2015 and features equipment and technologies, ventilation systems, and automated water systems to assure the highest standards of animal welfare, quality, biosecurity, and employee safety. The Envigo facility also supports Indian biomedical and biopharmaceutical researchers with a variety of inbred mouse models to advance their studies.
John Handley, president of EMEA Operations said, “I am delighted that our team and facility in India have been recognized by the industry-leading AAALAC accreditation. The quality of care and expertise at Hyderabad facility were highlighted by the auditors – a testament to the professionalism of our employees who work in partnership with customers around the world to advance research that makes the world a safer and healthier place. As non-clinical development continues to proliferate on a global basis, it is important for our local and Western customers to have access to high quality, proven research models to conduct their research in Asia.”
This is the first accreditation of Envigo sites in 2017 and the sixth in total since the launch of the new company in 2015. All of Envigo’s U.S. sites are already AAALAC accredited.
The isolator breeding facility in Hyderabad was purpose-built in 2015 and features equipment and technologies, ventilation systems, and automated water systems to assure the highest standards of animal welfare, quality, biosecurity, and employee safety. The Envigo facility also supports Indian biomedical and biopharmaceutical researchers with a variety of inbred mouse models to advance their studies.
John Handley, president of EMEA Operations said, “I am delighted that our team and facility in India have been recognized by the industry-leading AAALAC accreditation. The quality of care and expertise at Hyderabad facility were highlighted by the auditors – a testament to the professionalism of our employees who work in partnership with customers around the world to advance research that makes the world a safer and healthier place. As non-clinical development continues to proliferate on a global basis, it is important for our local and Western customers to have access to high quality, proven research models to conduct their research in Asia.”